Bliss Kelly sold $24K of TDOC
Bliss Kelly (President, U.S. Group Health) sold 2,500 shares of Teladoc Health, Inc. (TDOC) at $9.50 on 2026-07-06 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
This is a disclosed open-market sale by an officer (President, U.S. Group Health) for $23,750 total, executed the same day as the filing, under a pre-arranged 10b5-1 plan.
Market read
Traders may note the insider sale for sentiment monitoring, but the 10b5-1 structure limits interpretive value.
What to watch
The filing does not state intent or future trading; traders should avoid over-weighting small insider sales without corroborating fundamental catalysts.
Background
The article is an SEC Form 4 insider transaction disclosure for Teladoc Health, Inc. (TDOC).
Ticker impact
Teladoc Health Form 4 shows President, U.S. Group Health Bliss Kelly sold 2,500 shares on 2026-07-06 under a 10b5-1 plan.
Low likelihood of sustained price impact; any reaction is likely muted and short-lived.
The filing is a disclosed open-market sale by an officer, explicitly under a pre-arranged Rule 10b5-1 plan, with no accompanying operational or financial guidance changes.
Market effects
Minimal read-through to the broader digital health/telehealth sector; this is company-specific insider trading with no new business development.
None.
None.
Counterpoint
Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.
Key entities
- issuerTeladoc Health, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderBliss Kelly
President, U.S. Group Health; reported an open-market sale of 2,500 shares.
